TrialCancer immunology, immunotherapy : CII2014

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.

Caroline Jochems et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.